Creatine Deficiency Syndromes: Clinical Spectrum, Neuroimaging Features and Treatment Response
Abstract
Background: Creatine deficiency syndromes (CDS) are rare inborn errors of creatine biosynthesis or transport, predominantly affecting the central nervous system. This study aimed to evaluate the clinical features, neuroimaging findings, cardiac involvement and treatment outcomes of patients with CDS, while also increasing awareness of CDS in the differential diagnosis of autism spectrum disorder and developmental delay.
Methods: Patients diagnosed with CDS and followed at the Pediatric Metabolism Departments of Çukurova University and Adana City Hospital between 2014 and 2024 were retrospectively analysed. Demographic data, age at symptom onset and diagnosis, clinical findings, laboratory results, brain magnetic resonance imaging, magnetic resonance spectroscopy, genetic analyses, cardiological evaluations and treatment outcomes were recorded.
Results: Eight patients were included: two with arginine-glycine amidinotransferase (AGAT) deficiency, four with guanidinoacetate methyltransferase (GAMT) deficiency and two with creatine transporter deficiency (CTD). Developmental and speech delay were present in all patients. Seizures were observed in six patients and were controlled with antiepileptic therapy. Behavioural disorders, including autistic features, were detected in five patients. Brain MRS revealed reduced cerebral creatine peaks in evaluated patients. Cardiac evaluations showed no abnormalities in any patient. Follow-up MRS performed after treatment initiation in six…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Biportal endoscopic versus microscopic lumbar decompressive laminectomy in patients with spinal stenosis: A randomized controlled trial
- A whey protein-based multi-ingredient nutritional supplement stimulates gains in lean body mass and strength in healthy older men: A randomized controlled trial
- Supplement-based nutritional strategies to tackle frailty: A multifactorial, double-blind, randomized placebo-controlled trial
- A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
- Creatine supplementation (3 g/day) and bone health in older women: a 2-year, randomized, placebo-controlled trial
- A Multi-Ingredient Nutritional Supplement in Combination With Resistance Exercise and High-Intensity Interval Training Improves Cognitive Function and Increases N-3 Index in Healthy Older Men: A Randomized Controlled Trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.